Final analysis of the CLL2-GIVe trial: obinutuzumab, ibrutinib, and venetoclax for untreated CLL with del(17p)/TP53mut

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Huber, Henriette (VerfasserIn) , Tausch, Eugen (VerfasserIn) , Schneider, Christof (VerfasserIn) , Edenhofer, Simone (VerfasserIn) , Tresckow, Julia von (VerfasserIn) , Robrecht, Sandra (VerfasserIn) , Giza, Adam (VerfasserIn) , Zhang, Can (VerfasserIn) , Fürstenau, Moritz (VerfasserIn) , Dreger, Peter (VerfasserIn) , Ritgen, Matthias (VerfasserIn) , Illmer, Thomas (VerfasserIn) , Illert, Anna Lena (VerfasserIn) , Dürig, Jan (VerfasserIn) , Böttcher, Sebastian (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 14 September 2023
In: Blood
Year: 2023, Jahrgang: 142, Heft: 11, Pages: 961-972
ISSN:1528-0020
DOI:10.1182/blood.2023020013
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1182/blood.2023020013
Volltext
Verfasserangaben:Henriette Huber, Eugen Tausch, Christof Schneider, Simone Edenhofer, Julia von Tresckow, Sandra Robrecht, Adam Giza, Can Zhang, Moritz Fürstenau, Peter Dreger, Matthias Ritgen,Thomas Illmer, Anna Lena Illert, Jan Dürig,Sebastian Böttcher [und 10 weitere Personen]

MARC

LEADER 00000caa a2200000 c 4500
001 1897707290
003 DE-627
005 20241205160144.0
007 cr uuu---uuuuu
008 240805s2023 xx |||||o 00| ||eng c
024 7 |a 10.1182/blood.2023020013  |2 doi 
035 |a (DE-627)1897707290 
035 |a (DE-599)KXP1897707290 
035 |a (OCoLC)1475305661 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Huber, Henriette  |d 1986-  |e VerfasserIn  |0 (DE-588)1024151409  |0 (DE-627)719255511  |0 (DE-576)367696762  |4 aut 
245 1 0 |a Final analysis of the CLL2-GIVe trial  |b obinutuzumab, ibrutinib, and venetoclax for untreated CLL with del(17p)/TP53mut  |c Henriette Huber, Eugen Tausch, Christof Schneider, Simone Edenhofer, Julia von Tresckow, Sandra Robrecht, Adam Giza, Can Zhang, Moritz Fürstenau, Peter Dreger, Matthias Ritgen,Thomas Illmer, Anna Lena Illert, Jan Dürig,Sebastian Böttcher [und 10 weitere Personen] 
264 1 |c 14 September 2023 
300 |a 12 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
700 1 |a Tausch, Eugen  |e VerfasserIn  |4 aut 
700 1 |a Schneider, Christof  |e VerfasserIn  |4 aut 
700 1 |a Edenhofer, Simone  |e VerfasserIn  |4 aut 
700 1 |a Tresckow, Julia von  |e VerfasserIn  |4 aut 
700 1 |a Robrecht, Sandra  |e VerfasserIn  |4 aut 
700 1 |a Giza, Adam  |e VerfasserIn  |4 aut 
700 1 |a Zhang, Can  |e VerfasserIn  |4 aut 
700 1 |a Fürstenau, Moritz  |e VerfasserIn  |4 aut 
700 1 |a Dreger, Peter  |e VerfasserIn  |0 (DE-588)1028891881  |0 (DE-627)732699894  |0 (DE-576)376320966  |4 aut 
700 1 |a Ritgen, Matthias  |e VerfasserIn  |4 aut 
700 1 |a Illmer, Thomas  |e VerfasserIn  |4 aut 
700 1 |a Illert, Anna Lena  |d 1977-  |e VerfasserIn  |0 (DE-588)12985428X  |0 (DE-627)481958363  |0 (DE-576)297870726  |4 aut 
700 1 |a Dürig, Jan  |e VerfasserIn  |4 aut 
700 1 |a Böttcher, Sebastian  |d 1971-  |e VerfasserIn  |0 (DE-588)122679954  |0 (DE-627)705998363  |0 (DE-576)293377804  |4 aut 
773 0 8 |i Enthalten in  |t Blood  |d Washington, DC : American Society of Hematology, 1946  |g 142(2023), 11, Seite 961-972  |h Online-Ressource  |w (DE-627)266886647  |w (DE-600)1468538-3  |w (DE-576)075961938  |x 1528-0020  |7 nnas  |a Final analysis of the CLL2-GIVe trial obinutuzumab, ibrutinib, and venetoclax for untreated CLL with del(17p)/TP53mut 
773 1 8 |g volume:142  |g year:2023  |g number:11  |g pages:961-972  |g extent:12  |a Final analysis of the CLL2-GIVe trial obinutuzumab, ibrutinib, and venetoclax for untreated CLL with del(17p)/TP53mut 
856 4 0 |u https://doi.org/10.1182/blood.2023020013  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20240916 
993 |a Article 
994 |a 2023 
998 |g 1028891881  |a Dreger, Peter  |m 1028891881:Dreger, Peter  |d 910000  |d 910100  |e 910000PD1028891881  |e 910100PD1028891881  |k 0/910000/  |k 1/910000/910100/ 
999 |a KXP-PPN1897707290  |e 458026570X 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1897707290","origin":[{"dateIssuedDisp":"14 September 2023","dateIssuedKey":"2023"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"physDesc":[{"extent":"12 S."}],"id":{"doi":["10.1182/blood.2023020013"],"eki":["1897707290"]},"relHost":[{"corporate":[{"display":"American Society of Hematology","role":"isb"}],"note":["Gesehen am 21.04.2023"],"id":{"issn":["1528-0020"],"zdb":["1468538-3"],"eki":["266886647"]},"disp":"Final analysis of the CLL2-GIVe trial obinutuzumab, ibrutinib, and venetoclax for untreated CLL with del(17p)/TP53mutBlood","physDesc":[{"extent":"Online-Ressource"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"titleAlt":[{"title":"Blood online"}],"recId":"266886647","origin":[{"publisher":"American Society of Hematology ; Saunders ; HighWire Press","dateIssuedDisp":"1946-","dateIssuedKey":"1946","publisherPlace":"Washington, DC ; Philadelphia, Pa. ; Stanford, Calif."}],"language":["eng"],"part":{"volume":"142","year":"2023","text":"142(2023), 11, Seite 961-972","issue":"11","pages":"961-972","extent":"12"},"title":[{"title_sort":"Blood","title":"Blood","subtitle":"journal of the American Society of Hematology"}],"pubHistory":["1.1946 -"]}],"title":[{"title_sort":"Final analysis of the CLL2-GIVe trial","subtitle":"obinutuzumab, ibrutinib, and venetoclax for untreated CLL with del(17p)/TP53mut","title":"Final analysis of the CLL2-GIVe trial"}],"language":["eng"],"name":{"displayForm":["Henriette Huber, Eugen Tausch, Christof Schneider, Simone Edenhofer, Julia von Tresckow, Sandra Robrecht, Adam Giza, Can Zhang, Moritz Fürstenau, Peter Dreger, Matthias Ritgen,Thomas Illmer, Anna Lena Illert, Jan Dürig,Sebastian Böttcher [und 10 weitere Personen]"]},"person":[{"role":"aut","given":"Henriette","display":"Huber, Henriette","family":"Huber"},{"family":"Tausch","role":"aut","given":"Eugen","display":"Tausch, Eugen"},{"role":"aut","given":"Christof","display":"Schneider, Christof","family":"Schneider"},{"display":"Edenhofer, Simone","given":"Simone","role":"aut","family":"Edenhofer"},{"family":"Tresckow","display":"Tresckow, Julia von","role":"aut","given":"Julia von"},{"display":"Robrecht, Sandra","given":"Sandra","role":"aut","family":"Robrecht"},{"role":"aut","given":"Adam","display":"Giza, Adam","family":"Giza"},{"given":"Can","role":"aut","display":"Zhang, Can","family":"Zhang"},{"family":"Fürstenau","given":"Moritz","role":"aut","display":"Fürstenau, Moritz"},{"family":"Dreger","role":"aut","given":"Peter","display":"Dreger, Peter"},{"given":"Matthias","role":"aut","display":"Ritgen, Matthias","family":"Ritgen"},{"family":"Illmer","display":"Illmer, Thomas","given":"Thomas","role":"aut"},{"family":"Illert","display":"Illert, Anna Lena","given":"Anna Lena","role":"aut"},{"family":"Dürig","role":"aut","given":"Jan","display":"Dürig, Jan"},{"display":"Böttcher, Sebastian","role":"aut","given":"Sebastian","family":"Böttcher"}]} 
SRT |a HUBERHENRIFINALANALY1420